Business Context and Reporting Period
Company: DOMO, INC.
Filing Type: Form 8-K (Current Report)
Date of Report: September 6, 2024
Principal Executive Offices: American Fork, Utah
This filing reports the entry into a material definitive agreement to establish an "at-the-market" equity offering program.
Key Financial Metrics and Transaction Details
Transaction Type: Controlled Equity Offering SM Sales Agreement
Counterparty: Cantor Fitzgerald & Co. (Sales Agent)
Security: Class B Common Stock, par value $0.001 per share
Maximum Aggregate Proceeds: Up to $150,000,000
Commission Fee: 3.0% of aggregate gross proceeds from each sale
Financial Performance Data: The filing text does not provide a clear value for revenue, profit, cash flow, margins, debt, or liquidity metrics. This report focuses solely on the authorization of a potential capital raise.
Material Changes and Operational Mechanics
- Agreement Execution: On September 6, 2024, Domo entered into a Sales Agreement with Cantor Fitzgerald to sell shares from time to time.
- Sale Parameters: The Company retains discretion to set parameters including the number of shares, timing, daily limits, and minimum price thresholds.
- Regulatory Status: Shares will be issued pursuant to a Form S-3 Registration Statement filed on September 6, 2024. No sales may occur until the SEC declares the Registration Statement effective.
- Termination: Either party may terminate the agreement upon notice.
Guidance, Outlook, and Risks
Management Commentary: The Company has no obligation to sell any shares under the agreement and may suspend solicitation at any time. The agreement allows for flexibility in capital raising based on market conditions.
Risks and Contingencies:
- Regulatory Risk: The offering is contingent upon the effectiveness of the Form S-3 Registration Statement, which has not yet been declared effective by the SEC.
- Dilution Risk: The issuance of up to $150 million in new shares may dilute existing shareholders, depending on the market price at the time of sale.
- Market Risk: Sales are subject to market conditions and the Company's discretion regarding minimum price limits.
Investor Verification Checklist
- Verify the effectiveness status of the Form S-3 Registration Statement filed on September 6, 2024.
- Monitor future filings for the final prospectus supplement detailing specific share sales.
- Review the full text of the Sales Agreement (Exhibit 1.1) for specific termination clauses and indemnification terms.
- Assess the potential dilution impact of a $150 million equity raise on current share count and earnings per share.